SYRS logo

Syros Pharmaceuticals (SYRS)

Profile

Full Name

Syros Pharmaceuticals, Inc.

Ticker Symbol

SYRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 30, 2016

Indexes

Not included

Website

http://www.syros.com

Employees

68

Key Details

Price

$0.03(+7.88%)

Market cap

$697.64K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.94M(-33.23% YoY)

Annual EPS

-$5.81(+22.43% YoY)

PE ratio

-

Next earnings date

Apr 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.03
SYRS price is $0.03

30-Day Relative Volume

0.00
SYRS 30-day relative volume is 0.00

Price Performance

Price Today change

+7.88%
SYRS price is up +7.88% today

Price YTD change

-88.7%
SYRS price is down -88.7% since January 1st

Price 1-year change

-99.51%
SYRS price is down -99.51% year-on-year

Price 3-year change

-99.71%
SYRS price is down -99.71% over the past 3 years

Price Range

Price All-time high

$243.75
SYRS price is currently -99.99% below its historical high of $243.75

Price 3-year low

$0.01
SYRS price is currently +73.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$697.64K
SYRS market capitalization is $697.64 thousand

Market cap 3-year change

-98.77%
SYRS market capitalization is down -98.77% over the past 3 years

Market cap All-time high

$840.15M
SYRS market capitalization is currently -99.92% below its historical high of $840.15 million

Market cap sector rank

3.37%
SYRS market capitalization is higher than 3.37% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.39%
SYRS shares outstanding is up +0.39% year-on-year

Shares Outstanding 3-Year Change

+327.23%
SYRS shares outstanding is up +327.23% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.07
SYRS beta is 0.07

200-day SMA

$1.61
SYRS price is currently -98.38% below its 200-day simple moving average

50-day SMA

$0.10
SYRS price is currently -73.74% below its 50-day simple moving average

RSI

33.82
SYRS 14-day relative strength index is 33.82

Volume

0.00
SYRS 30-day relative volume is 0.00

ATR

$0.01
SYRS average true range is $0.01

10-day Historical Volatility

150.00%
SYRS 10-day historical volatility is 150.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$9.94M
SYRS annual revenue is $9.94 million

Revenue Analysts estimate

-
SYRS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-33.23%
SYRS annual revenue is down -33.23% year-on-year

Revenue Sector rank

27.66%
SYRS annual revenue is higher than 27.66% of companies in Healthcare sector

EPS

EPS

-$5.81
SYRS annual earnings per share is -$5.81

EPS Analysts estimate

-$1.61
SYRS annual earnings per share is currently +259.75% higher than the consensus analysts' forecast

EPS 1-year change

+22.43%
SYRS annual earnings per share is up +22.43% year-on-year

EPS Sector rank

17.2%
SYRS annual earnings per share is higher than 17.2% of companies in Healthcare sector

Profit

Gross profit

-
SYRS annual gross profit value is unknown

Gross margin

-
SYRS annual gross profit margin value is unknown

Operating profit

-$126.50M
SYRS annual operating income is -$126.50 million

Operating margin

-1273.14%
SYRS annual operating profit margin is -1273.14%

Net income

-$164.57M
SYRS annual net profit is -$164.57 million

Net margin

-1656.34%
SYRS annual net profit margin is -1656.34%

Expenses

Total expenses

$136.44M
SYRS annual total expenses is $136.44 million

Operating expenses

$136.44M
SYRS annual total operating expenses is $136.44 million

Cost of goods sold

-
SYRS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$28.28M
SYRS annual SGA is $28.28 million

Depreciation and amortization

$2.25M
SYRS annual depreciation & amortization is $2.25 million

Interest expense

$5.13M
SYRS annual interest expense is $5.13 million

Income tax

-
SYRS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$159.45M
SYRS annual earnings before interest & taxes is -$159.45 million

EBITDA

-$157.19M
SYRS annual EBITDA is -$157.19 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$168.17M
SYRS annual total assets is $168.17 million

Non current assets

$23.19M
SYRS annual long term assets is $23.19 million

Current assets

$144.98M
SYRS annual total current assets is $144.98 million

Cash and cash equivalents

$139.53M
SYRS annual cash & cash equivalents is $139.53 million

Accounts receivable

-
SYRS annual accounts receivable value is unknown

Inventory

-
SYRS annual inventory value is unknown

Liabilities

Total liabilities

$151.51M
SYRS annual total liabilities is $151.51 million

Long term liabilities

$114.83M
SYRS annual total long term liabilities is $114.83 million

Current liabilities

$36.68M
SYRS annual total current liabilities is $36.68 million

Accounts payable

$11.54M
SYRS annual accounts payable is $11.54 million

Debt

Total debt

$62.08M
SYRS annual total debt is $62.08 million

Total debt 1-year change

-2.35%
SYRS annual total debt is down -2.35% year-on-year

Long term debt

$53.08M
SYRS annual long term debt is $53.08 million

Short term debt

$8.99M
SYRS annual short term debt is $8.99 million

Equity & Capital

Shareholders equity

$16.66M
SYRS annual stockholders equity is $16.66 million

Book value

$16.66M
SYRS annual book value is $16.66 million

Retained earnings

-$722.81M
SYRS annual retained earnings is -$722.81 million

Working capital

$108.30M
SYRS annual working capital is $108.30 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$109.71M
SYRS annual cash flow from operations is -$109.71 million

Cash from operations 1-year change

+10.85%
SYRS annual cash flow from operations is up +10.85% year-on-year

Cash from investing

$37.34M
SYRS annual cash flow from investing activities is $37.34 million

Cash from investing 1-year change

-44.43%
SYRS annual cash flow from investing activities is down -44.43% year-on-year

Cash from financing

$43.46M
SYRS annual cash flow from financing activities is $43.46 million

Cash from financing 1-year change

-66.83%
SYRS annual cash flow from financing activities is down -66.83% year-on-year

CAPEX

CAPEX

$272.00K
SYRS annual capital expenditures is $272.00 thousand

CAPEX 1-year change

-78.08%
SYRS annual capital expenditures is down -78.08% year-on-year

Free Cash Flow

Free cash flow

-$109.98M
SYRS annual free cash flow is -$109.98 million

Free cash flow 1-year change

+11.53%
SYRS annual free cash flow is up +11.53% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SYRS annual gross profit margin value is unknown

Operating margin

-1273.14%
SYRS annual operating profit margin is -1273.14%

Net margin

-1656.34%
SYRS annual net profit margin is -1656.34%

ROA & ROE

ROA

-79.76%
SYRS annual return on assets is -79.76%

ROE

-227.95%
SYRS annual return on equity is -227.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SYRS price to earnings ratio value is unknown

PE ratio Sector rank

-
SYRS price to earnings ratio is unknown

PB Ratio

PB ratio

-0.06
SYRS price to book ratio is -0.06

PB ratio Sector rank

13.58%
SYRS price to book ratio is higher than 13.58% of companies in Healthcare sector

PS Ratio

PS ratio

-
SYRS price to sales ratio value is unknown

PS ratio Sector rank

-
SYRS price to sales ratio is unknown

Enterprise value

Enterprise value

$2.65M
SYRS enterprise value is $2.65 million

Enterprise value Sector rank

16.28%
SYRS enterprise value is higher than 16.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.03
SYRS EV/EBITDA is -0.03

EV/EBITDA Sector rank

63.83%
SYRS EV/EBITDA is higher than 63.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.95
SYRS annual current ratio is 3.95

Quick ratio

-
SYRS annual quick ratio value is unknown

Leverage

Debt to equity

2.47
SYRS annual debt to equity ratio is 2.47

Interest coverage ratio

-31.10
SYRS annual interest coverage ratio is -31.10

Risk & Stability

Piotroski F-Score

-
SYRS piotroski f-score value is unknown

Altman Z-Score

-8.31
SYRS altman z-score is -8.31

Analyst ratings

Recent major analysts updates

Nov 13, 24 TD Cowen
Hold
Nov 13, 24 JMP Securities
Market Perform
Nov 13, 24 HC Wainwright & Co.
Neutral
Nov 13, 24 Brookline Capital
Hold
Nov 1, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Piper Sandler
Overweight
Aug 13, 24 JMP Securities
Market Outperform
Aug 13, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jun 26, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

SCPX logo
Scorpius Holdings (SCPX)
NIVF logo
NewGenIvf Group Limited (NIVF)
STSS logo
Sharps Technology (STSS)
ONCO logo
Onconetix (ONCO)
TNF Pharmaceuticals (TNFA)
SONX logo
Sonendo (SONX)
LGMK logo
LogicMark (LGMK)
VIRX logo
Viracta Therapeutics (VIRX)
SRNE logo
Sorrento Therapeutics (SRNE)
  • What is the ticker symbol for Syros Pharmaceuticals?
  • Does Syros Pharmaceuticals pay dividends?
  • What sector is Syros Pharmaceuticals in?
  • What industry is Syros Pharmaceuticals in?
  • What country is Syros Pharmaceuticals based in?
  • When did Syros Pharmaceuticals go public?
  • Is Syros Pharmaceuticals in the S&P 500?
  • Is Syros Pharmaceuticals in the NASDAQ 100?
  • Is Syros Pharmaceuticals in the Dow Jones?
  • When was Syros Pharmaceuticals's last earnings report?
  • When does Syros Pharmaceuticals report earnings?
  • Should I buy Syros Pharmaceuticals stock now?

What is the ticker symbol for Syros Pharmaceuticals?

The ticker symbol for Syros Pharmaceuticals is NASDAQ:SYRS

Does Syros Pharmaceuticals pay dividends?

No, Syros Pharmaceuticals does not pay dividends

What sector is Syros Pharmaceuticals in?

Syros Pharmaceuticals is in the Healthcare sector

What industry is Syros Pharmaceuticals in?

Syros Pharmaceuticals is in the Biotechnology industry

What country is Syros Pharmaceuticals based in?

Syros Pharmaceuticals is headquartered in United States

When did Syros Pharmaceuticals go public?

Syros Pharmaceuticals's initial public offering (IPO) was on June 30, 2016

Is Syros Pharmaceuticals in the S&P 500?

No, Syros Pharmaceuticals is not included in the S&P 500 index

Is Syros Pharmaceuticals in the NASDAQ 100?

No, Syros Pharmaceuticals is not included in the NASDAQ 100 index

Is Syros Pharmaceuticals in the Dow Jones?

No, Syros Pharmaceuticals is not included in the Dow Jones index

When was Syros Pharmaceuticals's last earnings report?

Syros Pharmaceuticals's most recent earnings report was on Oct 31, 2024

When does Syros Pharmaceuticals report earnings?

The next expected earnings date for Syros Pharmaceuticals is Apr 17, 2025

Should I buy Syros Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page